Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRI
476
DELISTED
Atrion Corp
ATRI
| $31M | 0.04% |
44,400
-1,300
| -3% | -$863K |
|
477
Kulicke & Soffa
KLIC
$5.01B
| $30.8M | 0.04% |
528,728
+406,900
| +334% | +$25.3M |
|
478
Synaptics
SYNA
$4.2B
| $30.8M | 0.04% |
171,227
-82,900
| -33% | -$13.9M |
|
479
Darling Ingredients
DAR
$10.4B
| $30.8M | 0.04% |
427,798
-97,002
| -18% | -$6.94M |
|
|
PAMT
480
PAMT Corp
PAMT
$285M
| $30.7M | 0.04% |
1,365,408
-11,800
| -0.9% | -$203K |
|
481
Avery Dennison
AVY
$13.6B
| $30.5M | 0.04% |
147,400
+5,000
| +4% | +$1.07M |
|
482
Gerdau
GGB
$9.42B
| $30.4M | 0.04% |
7,784,328
+155,280
| +2% | +$676K |
|
|
WBK
483
DELISTED
Westpac Banking Corporation
WBK
| $30.4M | 0.04% |
1,639,161
-109,213
| -6% | -$2.04M |
|
|
ALX
484
Alexander's
ALX
$1.4B
| $30.3M | 0.04% |
116,098
-1,116
| -1% | -$298K |
|
|
CHS
485
DELISTED
Chicos FAS, Inc.
CHS
| $30.2M | 0.04% |
6,731,700
-186,100
| -3% | -$1.06M |
|
486
Sumitomo Mitsui Financial
SMFG
$167B
| $30.1M | 0.04% |
4,300,470
-932,300
| -18% | -$6.49M |
|
487
Travere Therapeutics
TVTX
$5.79B
| $30.1M | 0.04% |
1,240,418
-470,904
| -28% | -$8.65M |
|
488
Gartner
IT
$11.6B
| $30.1M | 0.04% |
98,909
-176,500
| -64% | -$51.2M |
|
489
Anika Therapeutics
ANIK
$283M
| $30M | 0.04% |
704,017
-14,700
| -2% | -$605K |
|
490
REX American Resources
REX
$1.44B
| $30M | 0.04% |
2,250,630
-43,200
| -2% | -$584K |
|
|
BRSL
491
Brightstar Lottery PLC
BRSL
$2.15B
| $29.8M | 0.04% |
1,131,000
-354,856
| -24% | -$7.52M |
|
492
Bio-Rad Laboratories Class A
BIO
$9.66B
| $29.5M | 0.04% |
39,600
-7,300
| -16% | -$5.47M |
|
493
BioMarin Pharmaceuticals
BMRN
$13.3B
| $29.5M | 0.04% |
381,471
+91,500
| +32% | +$7.22M |
|
|
NFBK
494
DELISTED
Northfield Bancorp
NFBK
| $29.5M | 0.04% |
1,716,451
-89,100
| -5% | -$1.47M |
|
495
Seaboard Corp
SEB
$4.08B
| $29.4M | 0.04% |
7,166
-126
| -2% | -$508K |
|
496
Johnson Outdoors
JOUT
$512M
| $29.2M | 0.04% |
276,400
-24,200
| -8% | -$2.76M |
|
|
TELL
497
DELISTED
Tellurian Inc.
TELL
| $29.2M | 0.04% |
7,467,500
+195,300
| +3% | +$667K |
|
|
IBA
498
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $29.2M | 0.04% |
660,545
-10,000
| -1% | -$448K |
|
499
Clearway Energy Class C
CWEN
$7.02B
| $29.1M | 0.04% |
962,322
-405,745
| -30% | -$12.1M |
|
500
Agilent Technologies
A
$42.2B
| $29.1M | 0.04% |
+184,900
| New | +$29.9M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.